Keywords
Insulin aspartate
Clinical application
Security analysis
Submitted : 2024-12-08
Accepted : 2024-12-23
Published : 2025-01-07
Abstract
Gestational diabetes mellitus (GDM) is a common metabolic disorder during pregnancy, which has a high incidence and has a serious impact on maternal and infant health, including premature delivery, macrosomia and postpartum complications. Therefore, timely and effective treatment is particularly important. The purpose of this study was to investigate the clinical value of insulin aspartate in the management of gestational diabetes mellitus, and to provide evidence for improving the treatment of gestational diabetes mellitus. Through the comprehensive analysis of the pharmacological properties and clinical applications of insulin aspartate, the research results showed that insulin aspartate can effectively control blood sugar levels and reduce adverse pregnancy outcomes in the treatment of gestational diabetes mellitus. It is worth noting that during the use of insulin aspartate, the impact on the mother and child is relatively small, and does not affect breastfeeding, reflecting its importance in the treatment of gestational diabetes. To provide a new treatment idea for the clinical management of gestational diabetes mellitus, emphasize the importance of individualized treatment, and lay a foundation for future related research.
References
Song M, Tian C, Zhu Q, 2019, Effects of Metformin Combined with Insulin Aspartate on Blood Glucose Level and Maternal and Infant Outcomes in Patients with Gestational Diabetes Mellitus. New World of Diabetes Mellitus, 26(10): 104–107.
Wang C, Zhu Y, Liu F, 2013, Effects of Vitamin D Combined with Insulin Aspartate on Glycolipid Metabolism and Insulin Resistance in Gestational Diabetes Mellitus. Journal of Medical Informatics, 36(7): 131–134.
Wei R, Zhou L, Wang J, 2002, Effects of Insulin Detemide Combined with Insulin Aspartate, Diet, and Exercise on Blood Glucose Index and Maternal and Infant Outcomes of Gestational Diabetes Mellitus. New World of Diabetes Mellitus, 25(23): 85–87 + 91.
Xu S, Zhen M, Long X, et al., 2019, Effect of Insulin Aspartate Combined with High-Dose Vitamin D Regimen on Neonatal Hypocalcemia of Gestational Diabetes Mellitus. Chinese Journal of Drug Abuse Prevention and Control, 28(11): 1607–1610.
Guo X, Xiao S, Wen X, 2019, Effects of Insulin Aspartate on Blood Glucose and Glycated Hemoglobin in Patients with Gestational Diabetes Mellitus. Journal of Clinical Rational Use of Medicine, 15(25): 82–84.
Niu X, Fang Y, Qiang D, et al., 2019, Effect of Insulin Aspartate Combined with Vitamin D in the Treatment of Gestational Diabetes Mellitus. Ningxia Medical Journal, 44(8): 728–730.
Amei M, Yan’e C, Yongmei L, et al., 2022, Exercise-Diet Therapy Combined with Insulin Aspartate Injection for the Treatment of Gestational Diabetes Mellitus: A Study on Clinical Effect and Its Impact. Computational and Mathematical Methods in Medicine, 2022: 488061–4882061.
Meng X, 2022, Clinical Effect Analysis of Insulin Aspartate Combined with Nutrition and Exercise Intervention in Patients with Gestational Diabetes Mellitus. Journal of Hebei Medicine, 44(11): 1650–1653.
Bi L, Yong M, Feng J, 2022, Clinical Value of Vitamin D Adjuvant Insulin Aspartate in the Treatment of Gestational Diabetes Mellitus. Ningxia Medical Journal, 44(5): 447–449.
Yang L, Yu H, Huang C, 2022, Effect of Insulin Aspartate in Patients with Gestational Diabetes Mellitus and Analysis of Pregnancy Outcomes. China Maternal and Child Health Care, 37(10): 1785–1787.
Wang L, 2022, Observing the Effect of Subcutaneous Injection of Insulin Aspartate in the Treatment of Gestational Diabetes Mellitus with Sleep Disorders and Its Effect on Pregnancy Outcome and Sleep Quality in Pregnant Women. World Journal of Sleep Medicine, 9(4): 664–667.
Liu Y, Liu X, Chen L, 2019, Effects of Dietary Intervention Combined with Insulin Aspartate on Blood Glucose Control and Maternal and Infant Outcomes of Gestational Diabetes Mellitus. Journal of Clinical Research, 30(1): 84–87.
Zhang X, Wang Y, Su Q, 2021, Effects of Glimepiride Combined with Insulin Aspartate on Insulin Resistance and Islet Cell Secretion in Patients with Gestational Diabetes Mellitus. Hainan Medical Science, 32(23): 3054–3057.
Zhang Y, Zhong L, Zeng H, 2021, Effect of Insulin Detemide Combined with Insulin Aspartate on Maternal and Infant Outcomes of Gestational Diabetes Mellitus. New World of Diabetes Mellitus, 24(15): 81–84.
Zhang M, 2019, Clinical Effect of Subcutaneous Insulin Aspartate Injection Combined with Protamine Biosynthetic Human Insulin in the Treatment of Gestational Diabetes Mellitus. Journal of Shanxi Health Vocational College, 31(2): 73–75.
Xu X, Wang Q, Hu X, 2019, Effect of Precision Nutrition Management Combined with Insulin Aspartate on Blood Glucose and Hemodynamics in Patients with Gestational Diabetes Mellitus. Shanghai Journal of Medicine, 41(23): 46–48 + 84.
Wang Z, Wu S, 2019, Clinical Observation of Insulin Aspartate and Insulin Detemide in the Treatment of Gestational Diabetes Mellitus. Shanghai Journal of Medicine, 41(20): 30–33.
Xu Y, Zhou S, Xiao B, 2020, Application of Insulin Aspartate Combined with Metformin in Patients with Gestational Diabetes Mellitus. Clinical Journal of Practical Hospital, 17(3): 155–158.
Fan S, Dong W, Liu W, et al., 2020, Effect of Calcium Carbonate D3 Combined with Insulin Aspartate on Patients with Gestational Diabetes Mellitus. Journal of Contemporary Medicine, 18(7): 159–160.
Lu L, Chen Q, Luo X, et al., 2019, Effect of Premixed Insulin Aspartate Injected by Insulin Pump and Subcutaneous Injection of Recombinant Human Insulin in the Treatment of Gestational Diabetes Mellitus and Its Influence on Pregnancy Outcome. Journal of Clinical Medicine, 39(9): 107–108.